1. Home
  2. HSDT vs PBM Comparison

HSDT vs PBM Comparison

Compare HSDT & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HSDT
  • PBM
  • Stock Information
  • Founded
  • HSDT N/A
  • PBM 1994
  • Country
  • HSDT United States
  • PBM Canada
  • Employees
  • HSDT N/A
  • PBM N/A
  • Industry
  • HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PBM
  • Sector
  • HSDT Health Care
  • PBM
  • Exchange
  • HSDT Nasdaq
  • PBM NYSE
  • Market Cap
  • HSDT 2.5M
  • PBM 2.7M
  • IPO Year
  • HSDT N/A
  • PBM N/A
  • Fundamental
  • Price
  • HSDT $1.09
  • PBM $5.52
  • Analyst Decision
  • HSDT Hold
  • PBM
  • Analyst Count
  • HSDT 1
  • PBM 0
  • Target Price
  • HSDT N/A
  • PBM N/A
  • AVG Volume (30 Days)
  • HSDT 2.2M
  • PBM 195.3K
  • Earning Date
  • HSDT 05-01-2025
  • PBM 07-07-2025
  • Dividend Yield
  • HSDT N/A
  • PBM N/A
  • EPS Growth
  • HSDT N/A
  • PBM N/A
  • EPS
  • HSDT N/A
  • PBM N/A
  • Revenue
  • HSDT $434,000.00
  • PBM N/A
  • Revenue This Year
  • HSDT $0.04
  • PBM N/A
  • Revenue Next Year
  • HSDT $75.10
  • PBM N/A
  • P/E Ratio
  • HSDT N/A
  • PBM N/A
  • Revenue Growth
  • HSDT N/A
  • PBM N/A
  • 52 Week Low
  • HSDT $0.80
  • PBM $2.93
  • 52 Week High
  • HSDT $24.00
  • PBM $701.82
  • Technical
  • Relative Strength Index (RSI)
  • HSDT 21.24
  • PBM 58.10
  • Support Level
  • HSDT $0.80
  • PBM $4.52
  • Resistance Level
  • HSDT $4.10
  • PBM $5.80
  • Average True Range (ATR)
  • HSDT 0.49
  • PBM 0.93
  • MACD
  • HSDT -0.28
  • PBM 0.08
  • Stochastic Oscillator
  • HSDT 6.61
  • PBM 39.21

About HSDT Helius Medical Technologies Inc. (DE)

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Share on Social Networks: